ISO 27001 Penetration Testing.
ISO/IEC 27001:2022 Annex A control testing. Evidence packaged for your certification body, not just for your binder.
ISO/IEC 27001:2022 Annex A control testing. Evidence packaged for your certification body, not just for your binder.
File · Where ISO
ISO/IEC 27001:2022 Annex A controls A.8.8 (Management of technical vulnerabilities) and A.8.29 (Security testing in development and acceptance) operationalize as documented, repeatable penetration testing on a defined cadence with remediation tracking and retest evidence.
Operator Note
A scanner report stapled to a corrective-action log rarely clears review. In our experience the certification body is looking for evidence that someone reasoned about the ISMS boundary as an attacker would, mapped each finding back to a specific Annex A control, and tracked it through the corrective-action process to closure. That traceability, from finding to control to fix, is what A.8.8 and A.8.29 are really asking you to produce.
File · Scope coverage
Testing mirrors your ISMS scope statement, and every finding lands in the format your auditor consumes:
File · FAQ
Q1 Will your report satisfy our certification body?
Yes. Reports are structured to map findings against Annex A and include the retest evidence auditors expect.
Q2 Annual cadence or per-change?
Both. We scope the annual program and re-engage for material system changes.
Q3 Does ISO 27001 require external testing?
It requires independent technical testing on a defined cadence. External vendors are the most common path to evidence.
Talk to an Operator
Real operators. Real attack paths. Real business impact. Talk to us about your security goals.
Related
The surfaces tied to your Statement of Applicability, and the framework teams pursue alongside.
How ISO 27001 Annex A testing fits alongside SOC 2, PCI, HIPAA, and CMMC.
Annex A control evidence for cloud-hosted scope.
Application-layer testing for in-scope systems.
The framework most teams pursue alongside ISO 27001.
How SaaS teams scope ISMS testing for enterprise reviews.
Retest evidence mapped to the risk treatment plan.